Table 1.
Cancer | North america | North america cohort | Europe | Asia | Multicontinent |
Esophageal | 22, 23, 10, 24 | 25 | 26 | 27, 28 | |
Gastric | 22, 23, 10, 24 | 25* | 26 | 27, 28 | 29* |
Colon | 1, 22, 30, 23, 10, 24 | 25 | 31, 32, 26 | 27, 28* | 33, 29* |
Rectal | 22, 23, 10, 24 | 25 | 31, 26 | 27, 28* | 29* |
Gallbladder | 10, 24 | 26 | 27 | ||
Pancreatic | 22, 10, 24 | 25 | 31, 26 | 34, 27, 35 | 29* |
Lung | 22, 23 | 36, 25* | 37, 38 | 28* | 29, 39 |
Breast | 4, 22, 30, 23, 10, 24 | 9, 31, 32, 26, 40 | |||
Uterine corpus | 22, 10, 24 | 41 | |||
Ovarian | 5, 22, 30, 10, 24 | 31, 26 | 33, 42, 29* | ||
Vulvar | 24, 43 | ||||
Prostate | 6, 22, 30, 10, 24 | 25* | 31, 32 | 29 | |
Bladder | 22, 10, 24 | 25* | 29* | ||
Renal | 22, 10, 24 | 25* | 33, 44, 29* | ||
Hodgkin's lymphoma | 10, 24 | 45, 46, 26 | |||
NHL | 22, 47, 10, 24 | 25* | 31, 46, 26 | 33 |
Marginally insignificant. References are indicated by numbers.